All Stories

  1. Tissue Factor Structure and Coagulation

    Article • March 2015, Bentham Science Publishers

    Dr Saulius Butenas

  2. The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood: comment

    Article • Journal of Thrombosis and Haemostasis, January 2015, Wiley

    Dr Saulius Butenas

  3. Platelets do not express the oxidized or reduced forms of tissue factor

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, March 2014, Elsevier

    Dr Saulius Butenas

  4. Endogenous factor VIII synthesis from the intron 22–inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A

    Article • Nature Reports Stem Cells, September 2013, Springer Science + Business Media

    Dr Saulius Butenas

  5. The nature of lipopolysaccharide-stimulated monocyte tissue factor activity

    Article • Blood Coagulation & Fibrinolysis, September 2013, Wolters Kluwer Health

    Dr Saulius Butenas

  6. Comparison of tissue factor proteins

    Article • Biological Chemistry, July 2013, De Gruyter

    Dr Saulius Butenas

  7. Disulfide reduction abolishes tissue factor cofactor function

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, June 2013, Elsevier

    Dr Saulius Butenas

  8. Product-dependent anti-factor VIII antibodies

    Article • Haemophilia, April 2013, Wiley

    Dr Saulius Butenas

  9. Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia

    Article • Thrombosis Research, December 2012, Elsevier

    Dr Saulius Butenas

  10. Platelet tissue factor is not expressed transiently after platelet activation

    Article • Blood, May 2012, American Society of Hematology

    Dr Saulius Butenas

  11. Tissue factor controversies

    Article • Thrombosis Research, May 2012, Elsevier

    Dr Saulius Butenas

  12. Decryption of tissue factor

    Article • Thrombosis Research, May 2012, Elsevier

    Dr Saulius Butenas

  13. Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients

    Article • Blood Coagulation & Fibrinolysis, April 2012, Wolters Kluwer Health

    Dr Saulius Butenas

  14. Measuring the mechanical properties of blood clots formed via the tissue factor pathway of coagulation

    Article • Analytical Biochemistry, March 2012, Elsevier

    Dr Saulius Butenas

  15. Posttranslational modifications of tissue factor

    Article • Frontiers in Bioscience, January 2012, Frontiers in Bioscience

    Dr Saulius Butenas

  16. Tissue Factor Structure and Function

    Article • Scientifica, January 2012, Hindawi Publishing Corporation

    Dr Saulius Butenas

  17. Anticoagulants and the Propagation Phase of Thrombin Generation

    Article • PLoS ONE, November 2011, PLOS

    Dr Saulius Butenas

  18. Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events

    Article • Thrombosis Research, November 2011, Elsevier

    Dr Saulius Butenas

  19. Activated protein C inhibitor for correction of thrombin generation in hemophilia A blood and plasma1

    Article • Journal of Thrombosis and Haemostasis, November 2011, Wiley

    Dr Saulius Butenas

  20. Activated factor XI and tissue factor in aortic stenosis

    Article • Blood Coagulation & Fibrinolysis, September 2011, Wolters Kluwer Health

    Dr Saulius Butenas

  21. Active tissue factor and activated factor XI in patients with acute ischemic cerebrovascular events

    Article • European Journal of Clinical Investigation, June 2011, Wiley

    Dr Saulius Butenas

  22. Differences in the fractional abundances of carbohydrates of natural and recombinant human tissue factor

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, April 2011, Elsevier

    Dr Saulius Butenas

  23. Activated factor XI and tissue factor in chronic obstructive pulmonary disease: Links with inflammation and thrombin generation

    Article • Thrombosis Research, March 2011, Elsevier

    Dr Saulius Butenas

  24. Alloantibodies to factor VIII in haemophilia

    Article • Haemophilia, February 2011, Wiley

    Dr Saulius Butenas

  25. Platelet-white blood cell (WBC) interaction, WBC apoptosis, and procoagulant activity in stored red blood cells

    Article • Transfusion, December 2010, Wiley

    Dr Saulius Butenas

  26. Cellular regulation of blood coagulation: a model for venous stasis

    Article • Blood, September 2010, American Society of Hematology

    Dr Saulius Butenas

  27. Activated factor XI and tissue factor in inflammatory bowel disease

    Article • Inflammatory Bowel Diseases, September 2010, Wolters Kluwer Health

    Dr Saulius Butenas

  28. No evidence for tissue factor on platelets

    Article • Blood, August 2010, American Society of Hematology

    Dr Saulius Butenas

  29. The “normal” factor VIII concentration in plasma

    Article • Thrombosis Research, August 2010, Elsevier

    Dr Saulius Butenas

  30. Anticoagulation by factor Xa inhibitors

    Article • Journal of Thrombosis and Haemostasis, May 2010, Wiley

    Dr Saulius Butenas

  31. Posttranslational modifications and activity of natural and recombinant tissue factor

    Article • Thrombosis Research, April 2010, Elsevier

    Dr Saulius Butenas

  32. Carbohydrates and Activity of Natural and Recombinant Tissue Factor

    Article • Journal of Biological Chemistry, December 2009, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Saulius Butenas

  33. Thromboelastography as a Better Indicator of Hypercoagulable State After Injury Than Prothrombin Time or Activated Partial Thromboplastin Time

    Article • Journal of Trauma and Acute Care Surgery, August 2009, Wolters Kluwer Health

    Dr Saulius Butenas

  34. Tissue Factor in Coagulation: Which? Where? When?

    Article • Arteriosclerosis Thrombosis and Vascular Biology, July 2009, Wolters Kluwer Health

    Dr Saulius Butenas

  35. Empirical and theoretical phenotypic discrimination

    Article • Journal of Thrombosis and Haemostasis, July 2009, Wiley

    Dr Saulius Butenas

  36. Discordant fibrin formation in hemophilia

    Article • Journal of Thrombosis and Haemostasis, May 2009, Wiley

    Dr Saulius Butenas

  37. Quantitation of anti-factor VIII antibodies in human plasma

    Article • Blood, January 2009, American Society of Hematology

    Dr Saulius Butenas

  38. The influence of von Willebrand factor on factor VIII activity measurements

    Article • Journal of Thrombosis and Haemostasis, January 2009, Wiley

    Dr Saulius Butenas

  39. Potency and mass of factor VIII in FVIII products

    Article • Haemophilia, January 2009, Wiley

    Dr Saulius Butenas

  40. The Nature of the Stable Blood Clot Procoagulant Activities

    Article • Journal of Biological Chemistry, February 2008, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Saulius Butenas

  41. Tissue factor activity and function in blood coagulation

    Article • Thrombosis Research, January 2008, Elsevier

    Dr Saulius Butenas

  42. Factor XIa and tissue factor activity in patients with coronary artery disease

    Article • Thrombosis and Haemostasis, December 2007, Schattauer GmbH

    Dr Saulius Butenas

  43. Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition

    Article • Journal of Thrombosis and Haemostasis, October 2007, Wiley

    Dr Saulius Butenas

  44. Tissue factor in thrombosis and hemorrhage

    Article • Surgery, October 2007, Elsevier

    Dr Saulius Butenas

  45. Citrate anticoagulation and the dynamics of thrombin generation

    Article • Journal of Thrombosis and Haemostasis, October 2007, Wiley

    Dr Saulius Butenas

  46. Influence of bivalirudin on tissue factor-triggered coagulation

    Article • Blood Coagulation & Fibrinolysis, July 2007, Wolters Kluwer Health

    Dr Saulius Butenas

  47. THROMBIN GENERATION PROFILES IN PATIENTS WITH ACUTE CORONARY SYNDROME AND STABLE CORONARY ARTERY DISEASE: A COMPUTATIONAL ANALYSIS

    Article • Journal of Thrombosis and Haemostasis, July 2007, Wiley

    Dr Saulius Butenas

  48. Caution in the interpretation of continuous thrombin generation assays

    Article • Journal of Thrombosis and Haemostasis, May 2007, Wiley

    Dr Saulius Butenas

  49. Interactions Between Platelets and the Coagulation System

    Article • January 2007, Elsevier

    Dr Saulius Butenas

  50. Peptidomimetic inhibitors for activated protein C: implications for hemophilia management

    Article • Journal of Thrombosis and Haemostasis, November 2006, Wiley

    Dr Saulius Butenas

  51. Immunologic quantitation of tissue factors

    Article • Journal of Thrombosis and Haemostasis, August 2006, Wiley

    Dr Saulius Butenas

  52. Models of blood coagulation

    Article • Blood Cells Molecules and Diseases, March 2006, Elsevier

    Dr Saulius Butenas

  53. Thrombin generation profiles in deep venous thrombosis

    Article • Journal of Thrombosis and Haemostasis, November 2005, Wiley

    Dr Saulius Butenas

  54. The Tissue Factor Requirement in Blood Coagulation

    Article • Journal of Biological Chemistry, October 2005, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Saulius Butenas

  55. Tissue factor activity in whole blood

    Article • Blood, April 2005, American Society of Hematology

    Dr Saulius Butenas

  56. Active tissue factor in blood?

    Article • Nature Reports Stem Cells, November 2004, Springer Science + Business Media

    Dr Saulius Butenas

  57. Does the genotype predict the phenotype? Evaluations of the hemostatic proteome

    Article • Journal of Thrombosis and Haemostasis, October 2004, Wiley

    Dr Saulius Butenas

  58. Factor VIIa replacement therapy in factor VII deficiency1

    Article • Journal of Thrombosis and Haemostasis, October 2004, Wiley

    Dr Saulius Butenas

  59. The Significance of Circulating Factor IXa in Blood

    Article • Journal of Biological Chemistry, March 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Saulius Butenas

  60. The Factor V Activation Paradox

    Article • Journal of Biological Chemistry, February 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Saulius Butenas

  61. The function of factor XI in tissue factor-initiated thrombin generation

    Article • Journal of Thrombosis and Haemostasis, October 2003, Wiley

    Dr Saulius Butenas

  62. What is all that thrombin for?

    Article • Journal of Thrombosis and Haemostasis, July 2003, Wiley

    Dr Saulius Butenas

  63. How factor VIIa works in hemophilia

    Article • Journal of Thrombosis and Haemostasis, March 2003, Wiley

    Dr Saulius Butenas

  64. Influence of Factor VIIa and Phospholipids on Coagulation in "Acquired" Hemophilia

    Article • Arteriosclerosis Thrombosis and Vascular Biology, October 2002, Wolters Kluwer Health

    Dr Saulius Butenas

  65. Mechanism of factor VIIa-dependent coagulation in hemophilia blood

    Article • Blood, February 2002, American Society of Hematology

    Dr Saulius Butenas

  66. Antiplatelet agents in tissue factor-induced blood coagulation

    Article • Blood, April 2001, American Society of Hematology

    Dr Saulius Butenas

  67. Homocysteine Inhibits Inactivation of Factor Va by Activated Protein C

    Article • Journal of Biological Chemistry, November 2000, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Saulius Butenas

  68. Models of blood coagulation

    Article • Blood Coagulation & Fibrinolysis, April 2000, Wolters Kluwer Health

    Dr Saulius Butenas

  69. An Integrated Study of Fibrinogen during Blood Coagulation

    Article • Journal of Biological Chemistry, August 1999, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Saulius Butenas

  70. Evaluation of the Initiation Phase of Blood Coagulation Using Ultrasensitive Assays for Serine Proteases

    Article • Journal of Biological Chemistry, August 1997, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Saulius Butenas

  71. Analysis of Tissue Plasminogen Activator Specificity Using Peptidyl Fluorogenic Substrates†

    Article • Biochemistry, February 1997, American Chemical Society (ACS)

    Dr Saulius Butenas

  72. Kinetics of Human Factor VII Activation †

    Article • Biochemistry, January 1996, American Chemical Society (ACS)

    Dr Saulius Butenas

  73. Fluorogenic Substrates for Activated Protein C: Substrate Structure-Efficiency Correlation

    Article • Analytical Biochemistry, March 1995, Elsevier

    Dr Saulius Butenas

  74. Cooperative Interaction of Divalent Metal Ions, Substrate, and Tissue Factor with Factor VIIa

    Article • Biochemistry, March 1994, American Chemical Society (ACS)

    Dr Saulius Butenas

  75. Synthetic substrates for human factor VIIa and factor VIIa-tissue factor

    Article • Biochemistry, July 1993, American Chemical Society (ACS)

    Dr Saulius Butenas

  76. [10] Extrinsic pathway proteolytic activity

    Article • January 1993, Elsevier

    Dr Saulius Butenas

  77. Aminonaphthalenesulfonamides, a new class of modifiable fluorescent detecting groups and their use in substrates for serine protease enzymes

    Article • Biochemistry, June 1992, American Chemical Society (ACS)

    Dr Saulius Butenas